<p>Number and percentages of participants with solicited adverse events after any vaccination, and unsolicited and serious adverse events throughout the study (safety set).</p
<p>Number of participants with at least one adverse event, and severity of the worst event per parti...
<p>Local adverse events that were reported twice by individual subjects (8 adverse events) in the se...
<p>(a) Post ChAd63 CS 5×10<sup>9</sup> vp; (b) Post ChAd63 CS 5×10<sup>10</sup> vp; (c) Post MVA CS ...
<p>Data are reported as: Number of participants with a serious adverse event (% [95% confidence inte...
(A) Frequency of possibly, probably and definitely related (“Related”) unsolicited adverse events fr...
Frequency of related solicited adverse events experienced at least once; recorded at peak severity g...
<p>Adverse events related to vaccination description and proportion of volunteers suffering any side...
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
<p>Bars represent the maximum severity per volunteers within 28 days after either 2 vaccinations in ...
<p>Data are number (%) of patients with at least one adverse event. The safety population consisted ...
<p>Solicited reactogenicity was collected for 7 days after each vaccination for 21 days total after ...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
<p>N: Number of subjects inoculated; n: Number of subjects with adverse events; E: Number of adverse...
<p>Proportion and number of participants with (A) local and (B) systemic solicited adverse events po...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
<p>Number of participants with at least one adverse event, and severity of the worst event per parti...
<p>Local adverse events that were reported twice by individual subjects (8 adverse events) in the se...
<p>(a) Post ChAd63 CS 5×10<sup>9</sup> vp; (b) Post ChAd63 CS 5×10<sup>10</sup> vp; (c) Post MVA CS ...
<p>Data are reported as: Number of participants with a serious adverse event (% [95% confidence inte...
(A) Frequency of possibly, probably and definitely related (“Related”) unsolicited adverse events fr...
Frequency of related solicited adverse events experienced at least once; recorded at peak severity g...
<p>Adverse events related to vaccination description and proportion of volunteers suffering any side...
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
<p>Bars represent the maximum severity per volunteers within 28 days after either 2 vaccinations in ...
<p>Data are number (%) of patients with at least one adverse event. The safety population consisted ...
<p>Solicited reactogenicity was collected for 7 days after each vaccination for 21 days total after ...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
<p>N: Number of subjects inoculated; n: Number of subjects with adverse events; E: Number of adverse...
<p>Proportion and number of participants with (A) local and (B) systemic solicited adverse events po...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
<p>Number of participants with at least one adverse event, and severity of the worst event per parti...
<p>Local adverse events that were reported twice by individual subjects (8 adverse events) in the se...
<p>(a) Post ChAd63 CS 5×10<sup>9</sup> vp; (b) Post ChAd63 CS 5×10<sup>10</sup> vp; (c) Post MVA CS ...